Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 1.000 | |
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.585 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.541 | |
| 2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
| 2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.522 | |
| 3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.518 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.516 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.503 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.503 | |
| 2cci | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.488 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.487 | |
| 1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
| 3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.483 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.475 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
| 2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.466 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
| 5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.465 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
| 4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
| 4s33 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.461 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.458 | |
| 3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.456 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.456 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.452 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
| 1ig1 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
| 1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.449 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.449 | |
| 5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.447 | |
| 3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.444 | |
| 1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.440 | |
| 5aut | 2AN | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 |